Stack Stack · multiple compounds
Retatrutide + MOTS-c
Community-popular pairing of retatrutide with MOTS-c, supplied as separate vials. No study has tested the combination; MOTS-c metabolic data come from cells and mice.
Community opinion
Why people pair them
Framed online as the main fat-loss driver plus a metabolic 'safety net' for training energy. Sold as named bundles by some vendors.
Example discussion (community, not a primary source)Primary sources
What the evidence shows
- Retatrutide has randomized human obesity data; MOTS-c was not part of it. Source
- MOTS-c improved insulin sensitivity and prevented diet-induced obesity in mice. Source
- A human MOTS-c study is registered (NCT07505745) with no posted results and no retatrutide arm. Source
Caveat: No combination safety data. FDA flags MOTS-c for immunogenicity, impurity and limited human-safety concerns.
What's in it
2 ingredients in separate vials. Tap one to open its own page.
- 01
Retatrutide
GIP / GLP-1 / glucagon triple agonist
Investigational triple-hormone receptor agonist evaluated in phase 2/3 obesity trials.
How it works: Retatrutide (LY3437943) is a single peptide agonist of three receptors: GIP, GLP-1 and glucagon.
Open Retatrutide → - 02
MOTS-c
Mitochondrial-genome-encoded peptide studied in cell and rodent metabolic models, including insulin sensitivity; these experiments do not establish human exercise-replacement or treatment benefits.
How it works: MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial 12S rRNA gene.
Open MOTS-c →
No schedule on file
This is a reference-only entry. The site lists its vial sizes and concentrations only — there is no published schedule for it here.
Laboratory reference · catalog presentation
- Research vial sizes
- 10 mg
- Dosing data
- Not listed — reference entry covers vial concentration only.
- Storage
- Follow the specific supplier's documented storage and stability conditions. Temperature, diluent compatibility and shelf life vary by compound and formulation; this catalog does not establish a universal post-mixing expiry.
Reconstitution concentrations
Calculated concentration by volume; 10 units = 0.1 mL on a U-100 syringe. These figures do not verify solubility, BAC-water compatibility, vial capacity or stability.
10 mg vial
1 mL water
10 mg/mL
1 mg / 10 u
2 mL water
5 mg/mL
0.5 mg / 10 u
3 mL water
3.33 mg/mL
0.333 mg / 10 u
| Vial | BAC water | mg/mL | mg per 10 u |
|---|---|---|---|
| 10 mg | 1 mL | 10 | 1 |
| 10 mg | 2 mL | 5 | 0.5 |
| 10 mg | 3 mL | 3.33 | 0.333 |
Notes
Vial size shown is a common MOTS-c listing; each compound comes in its own vial.
1
Notes
Vial size shown is a common MOTS-c listing; each compound comes in its own vial.
- Vial size shown is a common MOTS-c listing; each compound comes in its own vial.
Keep exploring
Similar stacks & blends
Research Use Only. Combination entries are laboratory reference data, not instructions for human use.Full disclaimer.